Published online Jun 14, 2024. doi: 10.3748/wjg.v30.i22.2852
Revised: May 4, 2024
Accepted: May 21, 2024
Published online: June 14, 2024
Processing time: 136 Days and 1 Hours
Diabetes, commonly known for its metabolic effects, also critically affects the enteric nervous system (ENS), which is essential in regulating gastrointestinal (GI) motility, secretion, and absorption. The development of diabetes-induced enteric neuropathy can lead to various GI dysfunctions, such as gastroparesis and irregular bowel habits, primarily due to disruptions in the function of neuronal and glial cells within the ENS, as well as oxidative stress and inflammation. This editorial explores the pathophysiological mechanisms underlying the develop
Core Tip: Diabetic enteric neuropathy, an often-overlooked complication of diabetes, significantly impacts gastrointestinal (GI) functions and impairs patients’ quality of life. This editorial examines the link between diabetes and enteric neuropathy, emphasizing its impact on essential GI functions. It discusses how diabetes-induced neuropathy leads to GI issues like gastroparesis and altered bowel habits and highlights recent advances in early diagnostic methods and management. The editorial reviews various treatment strategies, both current and emerging, addressing associated challenges and future directions. It stresses the importance of a multidisciplinary approach in managing this complication.
